INTRODUCTIONAtopic dermatitis (AD) is a chronic inflammatory disease affecting up to 15% of children and 3% of adults.1 Restoring barrier function with dermatologist-recommended gentle skin care is central to therapy.…
Read More
INTRODUCTIONRecent studies have demonstrated functional and cosmetic benefits with the use of hedgehog pathway inhibitors in the neoadjuvant setting for basal cell carcinoma (BCC). In one open label study, investigators…
Read More
INTRODUCTIONHyperpigmentation disorders, including melasma, post-inflammatory hyperpigmentation (PIH), dermal macular hyperpigmentation, seborrheic melanosis, hyperpigmentation associated with acanthosis nigricans, and solar lentigines, represent a set of pigmentary disorders that are usually characterized…
Read More
INTRODUCTIONAtopic dermatitis (AD) is a chronic relapsing-remitting condition that affects approximately 25% of children and 7% to 10% of adults globally.1 Pruritus (itch) is the most bothersome symptom for patients…
Read More
INTRODUCTIONAtopic dermatitis (AD), a chronic, relapsing inflammatory skin condition that affects approximately 20% of children and up to 10% of adults, is characterized by xerosis, localized or diffuse erythematous scaly…
Read More
INTRODUCTIONHyperkeratotic psoriatic plaques are associated with treatment difficulty and enhanced disease burden. For instance, patients with elevated plaques are less likely to achieve skin clearance with topical corticosteroids (TCSs) than…
Read More
INTRODUCTIONMany quality prescription products and procedures exist for the treatment of acne vulgaris. However, they often fall short of clinician and/or patient expectations resulting in insufficient control, cutaneous intolerability, unacceptable…
Read More
INTRODUCTIONDrug-induced photosensitivity is an adverse reaction to ultraviolet (UV) radiation triggered by medications like antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs), and psychotropics, with manifestations ranging from mild erythema to severe dermatitis.1…
Read More
INTRODUCTIONPhosphodiesterase-IV (PDE4) inhibitors represent a burgeoning frontier in dermatological care, offering targeted solutions to inflammatory skin diseases such as psoriasis, atopic dermatitis, and seborrheic dermatitis. PDE4 inhibitors function by increasing…
Read More
INTRODUCTIONAcne-induced macular hyperpigmentation (AMH) refers to post-inflammatory hyperpigmentation in acne and is common in patients with highly melanated skin.1 The Fitzpatrick Skin Type (FST) system categorizes patients based on skin…
Read More
INTRODUCTIONAcne is a chronic inflammatory disease of the pilosebaceous unit, affecting nearly 90% of individuals with onset occurring on or near puberty but potentially extending into adulthood.1 The American Academy…
Read More
